<!DOCTYPE html>
<html lang="fr">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Dashboard Hyperpigmentation - Laboratoire ACM</title>
    <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
    <script src="https://cdn.jsdelivr.net/npm/chartjs-plugin-datalabels@2"></script>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: #333;
            overflow-x: hidden;
        }

        .header {
            background: linear-gradient(135deg, #1e3c72 0%, #2a5298 100%);
            color: white;
            padding: 30px;
            text-align: center;
            box-shadow: 0 4px 20px rgba(0,0,0,0.3);
        }

        .header h1 {
            font-size: 2.5em;
            margin-bottom: 10px;
            text-shadow: 2px 2px 4px rgba(0,0,0,0.3);
        }

        .header p {
            font-size: 1.2em;
            opacity: 0.9;
        }

        .navigation {
            background: rgba(255,255,255,0.95);
            padding: 15px;
            display: flex;
            justify-content: center;
            gap: 15px;
            flex-wrap: wrap;
            box-shadow: 0 2px 10px rgba(0,0,0,0.1);
            sticky: top;
            top: 0;
            z-index: 100;
        }

        .nav-btn {
            padding: 12px 25px;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border: none;
            border-radius: 25px;
            cursor: pointer;
            font-size: 1em;
            font-weight: bold;
            transition: all 0.3s ease;
            box-shadow: 0 4px 15px rgba(0,0,0,0.2);
        }

        .nav-btn:hover {
            transform: translateY(-2px);
            box-shadow: 0 6px 20px rgba(0,0,0,0.3);
        }

        .nav-btn.active {
            background: linear-gradient(135deg, #f093fb 0%, #f5576c 100%);
        }

        .container {
            max-width: 1600px;
            margin: 30px auto;
            padding: 0 20px;
        }

        .section {
            display: none;
            animation: fadeIn 0.5s ease;
        }

        .section.active {
            display: block;
        }

        @keyframes fadeIn {
            from { opacity: 0; transform: translateY(20px); }
            to { opacity: 1; transform: translateY(0); }
        }

        .dashboard-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(400px, 1fr));
            gap: 25px;
            margin-bottom: 30px;
        }

        .card {
            background: white;
            border-radius: 15px;
            padding: 25px;
            box-shadow: 0 8px 30px rgba(0,0,0,0.12);
            transition: all 0.3s ease;
        }

        .card:hover {
            transform: translateY(-5px);
            box-shadow: 0 12px 40px rgba(0,0,0,0.2);
        }

        .card h2 {
            color: #2a5298;
            margin-bottom: 20px;
            font-size: 1.5em;
            border-bottom: 3px solid #667eea;
            padding-bottom: 10px;
        }

        .stat-box {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 25px;
            border-radius: 15px;
            text-align: center;
            margin: 15px 0;
            box-shadow: 0 6px 20px rgba(0,0,0,0.2);
        }

        .stat-number {
            font-size: 3em;
            font-weight: bold;
            margin: 10px 0;
        }

        .stat-label {
            font-size: 1.1em;
            opacity: 0.95;
        }

        .chart-container {
            position: relative;
            height: 350px;
            margin: 20px 0;
        }

        .insights-list {
            list-style: none;
            padding: 0;
        }

        .insights-list li {
            padding: 15px;
            margin: 10px 0;
            background: linear-gradient(90deg, #f093fb20 0%, #f5576c20 100%);
            border-left: 5px solid #f5576c;
            border-radius: 8px;
            transition: all 0.3s ease;
        }

        .insights-list li:hover {
            transform: translateX(5px);
            box-shadow: 0 4px 15px rgba(0,0,0,0.1);
        }

        .tag {
            display: inline-block;
            padding: 8px 15px;
            background: #667eea;
            color: white;
            border-radius: 20px;
            margin: 5px;
            font-size: 0.9em;
            font-weight: bold;
        }

        .competitor-card {
            background: linear-gradient(135deg, #ffecd2 0%, #fcb69f 100%);
            padding: 20px;
            border-radius: 12px;
            margin: 15px 0;
            box-shadow: 0 4px 15px rgba(0,0,0,0.1);
        }

        .competitor-card h3 {
            color: #c94b4b;
            margin-bottom: 10px;
        }

        .recommendation-box {
            background: linear-gradient(135deg, #a8edea 0%, #fed6e3 100%);
            padding: 25px;
            border-radius: 15px;
            margin: 20px 0;
            border: 3px solid #667eea;
            box-shadow: 0 6px 25px rgba(0,0,0,0.15);
        }

        .recommendation-box h3 {
            color: #1e3c72;
            margin-bottom: 15px;
            font-size: 1.4em;
        }

        .priority-high {
            border-left: 6px solid #f5576c;
            background: #fff5f5;
        }

        .priority-medium {
            border-left: 6px solid #ffa500;
            background: #fffaf0;
        }

        .priority-low {
            border-left: 6px solid #4caf50;
            background: #f1f8f4;
        }

        .swot-grid {
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 20px;
            margin: 20px 0;
        }

        .swot-card {
            padding: 20px;
            border-radius: 12px;
            box-shadow: 0 4px 15px rgba(0,0,0,0.1);
        }

        .swot-strengths { background: linear-gradient(135deg, #d4fc79 0%, #96e6a1 100%); }
        .swot-weaknesses { background: linear-gradient(135deg, #ffecd2 0%, #fcb69f 100%); }
        .swot-opportunities { background: linear-gradient(135deg, #a1c4fd 0%, #c2e9fb 100%); }
        .swot-threats { background: linear-gradient(135deg, #fccb90 0%, #d57eeb 100%); }

        .timeline {
            position: relative;
            padding: 20px 0;
        }

        .timeline-item {
            padding: 20px;
            margin: 15px 0;
            background: white;
            border-radius: 12px;
            border-left: 5px solid #667eea;
            box-shadow: 0 4px 15px rgba(0,0,0,0.1);
        }

        .filter-buttons {
            display: flex;
            gap: 10px;
            margin: 20px 0;
            flex-wrap: wrap;
        }

        .filter-btn {
            padding: 10px 20px;
            background: white;
            border: 2px solid #667eea;
            border-radius: 20px;
            cursor: pointer;
            transition: all 0.3s ease;
        }

        .filter-btn:hover, .filter-btn.active {
            background: #667eea;
            color: white;
        }

        .progress-bar {
            width: 100%;
            height: 30px;
            background: #e0e0e0;
            border-radius: 15px;
            overflow: hidden;
            margin: 10px 0;
        }

        .progress-fill {
            height: 100%;
            background: linear-gradient(90deg, #667eea 0%, #764ba2 100%);
            display: flex;
            align-items: center;
            justify-content: center;
            color: white;
            font-weight: bold;
            transition: width 1s ease;
        }

        .heatmap {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(150px, 1fr));
            gap: 15px;
            margin: 20px 0;
        }

        .heatmap-cell {
            padding: 25px;
            text-align: center;
            border-radius: 12px;
            color: white;
            font-weight: bold;
            transition: all 0.3s ease;
            cursor: pointer;
        }

        .heatmap-cell:hover {
            transform: scale(1.05);
        }

        .heat-very-high { background: #d32f2f; }
        .heat-high { background: #f57c00; }
        .heat-medium { background: #fbc02d; }
        .heat-low { background: #7cb342; }
        .heat-very-low { background: #0097a7; }

        @media (max-width: 768px) {
            .dashboard-grid {
                grid-template-columns: 1fr;
            }
            .swot-grid {
                grid-template-columns: 1fr;
            }
            .header h1 {
                font-size: 1.8em;
            }
        }

        .tooltip {
            position: relative;
            display: inline-block;
            cursor: help;
        }

        .tooltip .tooltiptext {
            visibility: hidden;
            width: 200px;
            background-color: #555;
            color: #fff;
            text-align: center;
            border-radius: 6px;
            padding: 10px;
            position: absolute;
            z-index: 1;
            bottom: 125%;
            left: 50%;
            margin-left: -100px;
            opacity: 0;
            transition: opacity 0.3s;
        }

        .tooltip:hover .tooltiptext {
            visibility: visible;
            opacity: 1;
        }

        .innovation-score {
            display: flex;
            align-items: center;
            justify-content: space-between;
            padding: 15px;
            background: linear-gradient(90deg, #f093fb 0%, #f5576c 100%);
            border-radius: 10px;
            color: white;
            margin: 10px 0;
        }

        .key-metric {
            text-align: center;
            padding: 20px;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-radius: 12px;
            margin: 15px 0;
        }

        .key-metric-value {
            font-size: 2.5em;
            font-weight: bold;
        }

        .key-metric-label {
            font-size: 1.1em;
            margin-top: 10px;
        }
    </style>
</head>
<body>
    <div class="header">
        <h1>üî¨ Dashboard Strat√©gique Hyperpigmentation</h1>
        <p>Analyse du march√© pour le Laboratoire ACM - D√©cisions Data-Driven</p>
    </div>

    <div class="navigation">
        <button class="nav-btn active" onclick="showSection('overview')">üìä Vue d'ensemble</button>
        <button class="nav-btn" onclick="showSection('market')">üåç March√© Global</button>
        <button class="nav-btn" onclick="showSection('innovation')">üí° Innovations</button>
        <button class="nav-btn" onclick="showSection('competition')">üéØ Concurrence</button>
        <button class="nav-btn" onclick="showSection('strategy')">üöÄ Strat√©gie ACM</button>
        <button class="nav-btn" onclick="showSection('regions')">üó∫Ô∏è Analyse R√©gionale</button>
    </div>

    <div class="container">
        <!-- SECTION 1: VUE D'ENSEMBLE -->
        <div id="overview" class="section active">
            <div class="dashboard-grid">
                <div class="card">
                    <h2>üìà March√© Global</h2>
                    <div class="stat-box">
                        <div class="stat-label">Valeur du march√© 2022</div>
                        <div class="stat-number">8,8 Mds $</div>
                    </div>
                    <div class="stat-box" style="background: linear-gradient(135deg, #f093fb 0%, #f5576c 100%);">
                        <div class="stat-label">Pr√©vision 2030</div>
                        <div class="stat-number">15,7 Mds $</div>
                    </div>
                    <div style="text-align: center; margin-top: 20px;">
                        <div class="tag">CAGR: +7.8%</div>
                        <div class="tag">Croissance soutenue</div>
                    </div>
                </div>

                <div class="card">
                    <h2>üë• Impact Consommateur</h2>
                    <div class="key-metric">
                        <div class="key-metric-value">50%</div>
                        <div class="key-metric-label">Souffrent d'hyperpigmentation</div>
                    </div>
                    <div class="key-metric" style="background: linear-gradient(135deg, #f093fb 0%, #f5576c 100%);">
                        <div class="key-metric-value">33%</div>
                        <div class="key-metric-label">Impact n√©gatif sur qualit√© de vie</div>
                    </div>
                    <div class="key-metric" style="background: linear-gradient(135deg, #fa709a 0%, #fee140 100%);">
                        <div class="key-metric-value">44%</div>
                        <div class="key-metric-label">Cherchent √† dissimuler</div>
                    </div>
                </div>

                <div class="card">
                    <h2>üéØ Types d'Hyperpigmentation</h2>
                    <div class="chart-container">
                        <canvas id="typesChart"></canvas>
                    </div>
                </div>

                <div class="card">
                    <h2>üîë Insights Cl√©s</h2>
                    <ul class="insights-list">
                        <li><strong>üåü Opportunit√© majeure:</strong> March√© en croissance forte (+78% d'ici 2030)</li>
                        <li><strong>‚ö†Ô∏è D√©fi principal:</strong> M√©lasma = pathologie chronique, taux de r√©cidive √©lev√©</li>
                        <li><strong>üíä Gold standard:</strong> Triple th√©rapie (HQ + tr√©tino√Øne + cortico) - 65.6% succ√®s</li>
                        <li><strong>üö´ Contrainte r√©glementaire:</strong> Hydroquinone interdite en Europe (cosm√©tique)</li>
                        <li><strong>‚ú® Innovation √©mergente:</strong> Thiamidol, Melasyl, Acide tranexamique</li>
                    </ul>
                </div>
            </div>

            <div class="card">
                <h2>üî¨ M√©canismes Physiopathologiques</h2>
                <div class="timeline">
                    <div class="timeline-item">
                        <h3>‚òÄÔ∏è Exposition UV</h3>
                        <p>Stimulation excessive de la m√©lanog√©n√®se ‚Üí Production accrue de m√©lanine ‚Üí Transfert vers k√©ratinocytes</p>
                    </div>
                    <div class="timeline-item">
                        <h3>üî• Inflammation Dermique</h3>
                        <p>Activation fibroblastes ‚Üí Production SCF ‚Üí Stimulation r√©cepteur c-kit ‚Üí Surproduction m√©lanine</p>
                    </div>
                    <div class="timeline-item">
                        <h3>ü©∏ Composante Vasculaire</h3>
                        <p>Prolif√©ration vaisseaux ‚Üí Surexpression VEGF ‚Üí Signaux pro-m√©lanog√©niques ‚Üí M√©lasma rebelle</p>
                    </div>
                    <div class="timeline-item">
                        <h3>‚ö° Hormones</h3>
                        <p>≈ístrog√®nes (grossesse, contraception) ‚Üí Aggravation m√©lasma ‚Üí Pouss√©es estivales</p>
                    </div>
                </div>
            </div>
        </div>

        <!-- SECTION 2: MARCH√â GLOBAL -->
        <div id="market" class="section">
            <div class="dashboard-grid">
                <div class="card">
                    <h2>üåç R√©partition G√©ographique du March√©</h2>
                    <div class="chart-container">
                        <canvas id="geoChart"></canvas>
                    </div>
                </div>

                <div class="card">
                    <h2>üìä Segmentation Client</h2>
                    <div class="chart-container">
                        <canvas id="segmentChart"></canvas>
                    </div>
                    <div style="margin-top: 20px;">
                        <div class="tag">80% femmes teint mat/fonc√©</div>
                        <div class="tag">Tous phototypes concern√©s</div>
                    </div>
                </div>
            </div>

            <div class="card">
                <h2>üó∫Ô∏è Heatmap: Intensit√© de Demande par R√©gion</h2>
                <div class="heatmap">
                    <div class="heatmap-cell heat-very-high">
                        <h3>Asie-Pacifique</h3>
                        <p>Tr√®s forte demande</p>
                        <p>50%+ du march√©</p>
                    </div>
                    <div class="heatmap-cell heat-high">
                        <h3>Afrique</h3>
                        <p>Forte demande</p>
                        <p>30-60% utilisent</p>
                    </div>
                    <div class="heatmap-cell heat-medium">
                        <h3>Am√©rique du Nord</h3>
                        <p>Demande moyenne</p>
                        <p>Communaut√©s cibl√©es</p>
                    </div>
                    <div class="heatmap-cell heat-low">
                        <h3>Europe</h3>
                        <p>Demande mod√©r√©e</p>
                        <p>Focus anti-√¢ge</p>
                    </div>
                    <div class="heatmap-cell heat-medium">
                        <h3>Moyen-Orient</h3>
                        <p>Demande moyenne</p>
                        <p>March√© structur√©</p>
                    </div>
                    <div class="heatmap-cell heat-high">
                        <h3>Am√©rique Latine</h3>
                        <p>Forte demande</p>
                        <p>Croissance rapide</p>
                    </div>
                </div>
            </div>

            <div class="card">
                <h2>üìà √âvolution des Tendances Marketing</h2>
                <ul class="insights-list">
                    <li><strong>Ancien:</strong> "Whitening" / "√âclaircissant" ‚Üí <strong>Nouveau:</strong> "Brightening" / "Illuminateur"</li>
                    <li><strong>Raison:</strong> √âviter connotations n√©gatives du colorisme</li>
                    <li><strong>Exemple:</strong> Fair & Lovely ‚Üí Glow & Lovely (Unilever, 2020)</li>
                    <li><strong>Positionnement:</strong> "Peau √©clatante de sant√©" vs "Peau plus blanche"</li>
                    <li><strong>Cible √©largie:</strong> Taches de soleil + marques d'acn√© (pas seulement blanchiment)</li>
                </ul>
            </div>

            <div class="dashboard-grid">
                <div class="card">
                    <h2>üéØ Top Recherches Google par Pays</h2>
                    <div style="padding: 15px;">
                        <div class="progress-bar">
                            <div class="progress-fill" style="width: 95%;">Pakistan - 95%</div>
                        </div>
                        <div class="progress-bar">
                            <div class="progress-fill" style="width: 88%;">Nigeria - 88%</div>
                        </div>
                        <div class="progress-bar">
                            <div class="progress-fill" style="width: 85%;">Ghana - 85%</div>
                        </div>
                        <div class="progress-bar">
                            <div class="progress-fill" style="width: 80%;">Inde - 80%</div>
                        </div>
                        <div class="progress-bar">
                            <div class="progress-fill" style="width: 75%;">Jama√Øque - 75%</div>
                        </div>
                    </div>
                </div>

                <div class="card">
                    <h2>‚öñÔ∏è Maturit√© du March√©</h2>
                    <div class="innovation-score">
                        <span>Asie-Pacifique</span>
                        <span style="font-size: 2em;">‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê</span>
                    </div>
                    <div class="innovation-score" style="background: linear-gradient(90deg, #667eea 0%, #764ba2 100%);">
                        <span>Europe / USA</span>
                        <span style="font-size: 2em;">‚≠ê‚≠ê‚≠ê‚≠ê</span>
                    </div>
                    <div class="innovation-score" style="background: linear-gradient(90deg, #fa709a 0%, #fee140 100%);">
                        <span>Afrique</span>
                        <span style="font-size: 2em;">‚≠ê‚≠ê‚≠ê</span>
                    </div>
                    <p style="margin-top: 15px; font-size: 0.9em; color: #666;">
                        <strong>Asie:</strong> Innovation constante, adoption large<br>
                        <strong>Europe/USA:</strong> March√© m√©dicalis√©, haute technologie<br>
                        <strong>Afrique:</strong> Transition vers produits s√ªrs et r√©glement√©s
                    </p>
                </div>
            </div>
        </div>

        <!-- SECTION 3: INNOVATIONS -->
        <div id="innovation" class="section">
            <div class="card">
                <h2>üí° Timeline des Innovations Majeures</h2>
                <div class="timeline">
                    <div class="timeline-item priority-high">
                        <h3>üèÜ Thiamidol (Beiersdorf)</h3>
                        <p><strong>Breakthrough:</strong> Criblage de 50 000 compos√©s ‚Üí Inhibiteur tyrosinase puissant (IC50 ~1 ¬µM)</p>
                        <p><strong>Performance:</strong> Plus efficace que hydroquinone, excellente tol√©rance</p>
                        <p><strong>R√©sultats:</strong> Am√©lioration visible en 4 semaines, utilisation long cours s√ªre</p>
                        <p><strong>Gamme:</strong> Eucerin Anti-Pigment (disponible grand public)</p>
                        <div class="tag">2019</div>
                        <div class="tag">Cosm√©tique</div>
                    </div>

                    <div class="timeline-item priority-high">
                        <h3>‚ö° Melasyl (L'Or√©al)</h3>
                        <p><strong>D√©veloppement:</strong> 18 ans de recherche, mol√©cule multi-patent√©e</p>
                        <p><strong>Cible:</strong> D√©sordres pigmentaires localis√©s (taches vieillesse, post-acn√©)</p>
                        <p><strong>Performance:</strong> Uniformise teint m√™me peaux fonc√©es, efface marques persistantes</p>
                        <p><strong>Gamme:</strong> La Roche-Posay Mela-B3, L'Or√©al Paris, Vichy</p>
                        <div class="tag">2023-2024</div>
                        <div class="tag">Innovation majeure</div>
                    </div>

                    <div class="timeline-item priority-medium">
                        <h3>üíä Acide Tranexamique</h3>
                        <p><strong>M√©canisme:</strong> Antifibrinolytique ‚Üí R√©duit mastocytes dermiques + n√©o-vascularisation</p>
                        <p><strong>Usage oral:</strong> 250-500 mg/jour pendant 3-6 mois pour m√©lasmas mod√©r√©s √† s√©v√®res</p>
                        <p><strong>Usage topique:</strong> 5% en cr√®me, blocage communications pro-m√©lanine</p>
                        <p><strong>R√©sultats:</strong> Am√©lioration notable m√™me cas rebelles, mais r√©cidive √† l'arr√™t</p>
                        <div class="tag">Hors AMM</div>
                        <div class="tag">Surveillance m√©dicale</div>
                    </div>

                    <div class="timeline-item priority-medium">
                        <h3>üß™ 4MSK Enhanced (Shiseido)</h3>
                        <p><strong>Innovation:</strong> Technologie "ionic liquid" avec b√©ta√Øne</p>
                        <p><strong>Performance:</strong> P√©n√©tration 2x plus profonde qu'avant</p>
                        <p><strong>Double action:</strong> Inhibe m√©lanog√©n√®se + Acc√©l√®re exfoliation pigment</p>
                        <p><strong>R√©sultat:</strong> Att√©nuation plus rapide des taches existantes</p>
                        <div class="tag">2025</div>
                        <div class="tag">Gal√©nique avanc√©e</div>
                    </div>

                    <div class="timeline-item priority-medium">
                        <h3>üåø Melasolv (AmorePacific)</h3>
                        <p><strong>M√©canisme unique:</strong> R√©prime expression tyrosinase (vs blocage direct)</p>
                        <p><strong>Avantage:</strong> √âvite d√©pigmentation excessive, plus s√ªr que ph√©nols classiques</p>
                        <p><strong>Bonus:</strong> Action sur hyperpigmentation li√©e √† pollution (particules fines)</p>
                        <p><strong>Formulation:</strong> Nanovecteurs/liposomes pour stabilit√© et p√©n√©tration optimales</p>
                        <div class="tag">K-Beauty</div>
                        <div class="tag">Anti-pollution</div>
                    </div>

                    <div class="timeline-item priority-low">
                        <h3>üî¨ Extraits Botaniques Anti-VEGF (Shiseido)</h3>
                        <p><strong>Tormentilla:</strong> Inhibe production VEGF-A par k√©ratinocytes irradi√©s</p>
                        <p><strong>Pyrola incarnata:</strong> Bloque stimulation m√©lanine par cellules endoth√©liales UV-induites</p>
                        <p><strong>Approche:</strong> Ciblage inflammation + vascularisation (pas seulement m√©lanine)</p>
                        <div class="tag">Multi-cible</div>
                        <div class="tag">Naturel</div>
                    </div>
                </div>
            </div>

            <div class="dashboard-grid">
                <div class="card">
                    <h2>üéØ Nouvelles Cibles Th√©rapeutiques</h2>
                    <div class="chart-container">
                        <canvas id="targetsChart"></canvas>
                    </div>
                </div>

                <div class="card">
                    <h2>üî¨ Technologies √âmergentes</h2>
                    <ul class="insights-list">
                        <li><strong>ü§ñ IA:</strong> Analyse temps r√©el images peau, quantification taches, routines personnalis√©es</li>
                        <li><strong>üß¨ Skin equivalents:</strong> Mod√®les peau reconstruite pigment√©e pour tests rapides</li>
                        <li><strong>üí° Photopharmacologie:</strong> Mol√©cules activables par lumi√®re laser (ciblage spatial pr√©cis)</li>
                        <li><strong>üì± Applications mobiles:</strong> Couplage appareils mesure + recommandations adapt√©es</li>
                        <li><strong>üî¨ Nanovecteurs:</strong> Liposomes encapsulant actifs pour biodisponibilit√© maximale</li>
                    </ul>
                </div>
            </div>

            <div class="card">
                <h2>‚öóÔ∏è Comparatif des Actifs D√©pigmentants</h2>
                <table style="width: 100%; border-collapse: collapse; margin-top: 20px;">
                    <thead style="background: linear-gradient(135deg, #667eea 0%, #764ba2 100%); color: white;">
                        <tr>
                            <th style="padding: 15px; text-align: left;">Actif</th>
                            <th style="padding: 15px;">Efficacit√©</th>
                            <th style="padding: 15px;">S√©curit√©</th>
                            <th style="padding: 15px;">Rapidit√©</th>
                            <th style="padding: 15px;">Statut</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr style="background: #f5f5f5;">
                            <td style="padding: 12px;"><strong>Hydroquinone 4%</strong></td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê</td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px;"><span class="tag" style="background: #f44336;">Interdit EU</span></td>
                        </tr>
                        <tr>
                            <td style="padding: 12px;"><strong>Thiamidol</strong></td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px;"><span class="tag" style="background: #4caf50;">Cosm√©tique</span></td>
                        </tr>
                        <tr style="background: #f5f5f5;">
                            <td style="padding: 12px;"><strong>Melasyl</strong></td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px;"><span class="tag" style="background: #4caf50;">Cosm√©tique</span></td>
                        </tr>
                        <tr>
                            <td style="padding: 12px;"><strong>Acide Tranexamique oral</strong></td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px;"><span class="tag" style="background: #ff9800;">Hors AMM</span></td>
                        </tr>
                        <tr style="background: #f5f5f5;">
                            <td style="padding: 12px;"><strong>Acide Az√©la√Øque 20%</strong></td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px;"><span class="tag" style="background: #4caf50;">Prescription</span></td>
                        </tr>
                        <tr>
                            <td style="padding: 12px;"><strong>Vitamine C</strong></td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê</td>
                            <td style="padding: 12px;"><span class="tag" style="background: #4caf50;">Cosm√©tique</span></td>
                        </tr>
                        <tr style="background: #f5f5f5;">
                            <td style="padding: 12px;"><strong>Niacinamide</strong></td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px;"><span class="tag" style="background: #4caf50;">Cosm√©tique</span></td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <!-- SECTION 4: CONCURRENCE -->
        <div id="competition" class="section">
            <div class="card">
                <h2>üèÜ Mapping Concurrentiel</h2>
                <div class="competitor-card">
                    <h3>L'Or√©al (Leader mondial)</h3>
                    <p><strong>Atouts:</strong> Melasyl (18 ans R&D), Mexoryl 400 UVA, multi-marques (La Roche-Posay, Vichy, Lanc√¥me)</p>
                    <p><strong>Positionnement:</strong> Premium + Pharmacie, base scientifique forte</p>
                    <p><strong>Innovation r√©cente:</strong> Mela-B3 serum, expansion Vichy/L'Or√©al Paris avec Melasyl</p>
                    <div class="tag">Budget R&D: +++</div>
                    <div class="tag">Couverture globale</div>
                </div>

                <div class="competitor-card" style="background: linear-gradient(135deg, #fad0c4 0%, #ffd1ff 100%);">
                    <h3>Beiersdorf (Eucerin)</h3>
                    <p><strong>Atouts:</strong> Thiamidol (criblage 50k compos√©s), efficacit√© prouv√©e > HQ, excellent profil s√©curit√©</p>
                    <p><strong>Positionnement:</strong> Pharmacie, validation dermatologique forte</p>
                    <p><strong>Gamme:</strong> Anti-Pigment (s√©rum + cr√®me SPF), adoption dermatos</p>
                    <div class="tag">Innovation majeure</div>
                    <div class="tag">OTC Europe</div>
                </div>

                <div class="competitor-card" style="background: linear-gradient(135deg, #a8edea 0%, #fed6e3 100%);">
                    <h3>Shiseido (Leader Asie)</h3>
                    <p><strong>Atouts:</strong> 4MSK ionic liquid (p√©n√©tration 2x), extraits anti-VEGF, m-Tranexamic Acid (ann√©es 80)</p>
                    <p><strong>Positionnement:</strong> Premium, haute technologie gal√©nique</p>
                    <p><strong>Gamme historique:</strong> White Lucent, Ultimune, recherche inflammation/vascularisation</p>
                    <div class="tag">Pionnier Japon</div>
                    <div class="tag">Expertise gal√©nique</div>
                </div>

                <div class="competitor-card" style="background: linear-gradient(135deg, #ffecd2 0%, #fcb69f 100%);">
                    <h3>AmorePacific (K-Beauty)</h3>
                    <p><strong>Atouts:</strong> Melasolv (r√©prime expression tyrosinase), nanovecteurs, action anti-pollution</p>
                    <p><strong>Positionnement:</strong> Innovation K-Beauty, s√©rums/masques √©claircissants</p>
                    <p><strong>Marques:</strong> Sulwhasoo, Laneige - popularit√© mondiale K-Beauty</p>
                    <div class="tag">Alternative HQ s√ªre</div>
                    <div class="tag">Trend K-Beauty</div>
                </div>

                <div class="competitor-card" style="background: linear-gradient(135deg, #d4fc79 0%, #96e6a1 100%);">
                    <h3>Galderma</h3>
                    <p><strong>Atouts:</strong> Skinoren (az√©la√Øque), Tri-Luma USA (triple th√©rapie), expertise dermatologique</p>
                    <p><strong>Positionnement:</strong> Prescription, solutions m√©dicales</p>
                    <div class="tag">Dermato pure-player</div>
                </div>

                <div class="competitor-card" style="background: linear-gradient(135deg, #e0c3fc 0%, #8ec5fc 100%);">
                    <h3>Marques √©mergentes (Topicals, The Ordinary, etc.)</h3>
                    <p><strong>Atouts:</strong> Formules transparentes, multi-actifs (tranexamique + niacinamide + az√©la√Øque), communaut√© forte</p>
                    <p><strong>Positionnement:</strong> Direct-to-consumer, prix accessibles, √©ducation consommateur</p>
                    <p><strong>Cible:</strong> Millennials/Gen Z, peaux noires et asiatiques</p>
                    <div class="tag">D2C</div>
                    <div class="tag">Social media</div>
                </div>
            </div>

            <div class="dashboard-grid">
                <div class="card">
                    <h2>üìä Parts de March√© Estim√©es</h2>
                    <div class="chart-container">
                        <canvas id="marketShareChart"></canvas>
                    </div>
                </div>

                <div class="card">
                    <h2>üî¨ Budget R&D Investissement</h2>
                    <div class="chart-container">
                        <canvas id="rdBudgetChart"></canvas>
                    </div>
                </div>
            </div>

            <div class="card">
                <h2>‚ö° Avantages Concurrentiels Cl√©s</h2>
                <div class="swot-grid">
                    <div class="swot-card swot-strengths">
                        <h3>üí™ L'Or√©al</h3>
                        <ul>
                            <li>18 ans R&D Melasyl</li>
                            <li>Multi-marques (masstige ‚Üí luxury)</li>
                            <li>Distribution mondiale massive</li>
                            <li>Pipeline innovation fort</li>
                        </ul>
                    </div>
                    <div class="swot-card swot-opportunities">
                        <h3>üéØ Beiersdorf</h3>
                        <ul>
                            <li>Thiamidol: alternative HQ valid√©e</li>
                            <li>Adoption dermatologues rapide</li>
                            <li>Profil s√©curit√© excellent</li>
                            <li>Pharmacie mainstream</li>
                        </ul>
                    </div>
                    <div class="swot-card swot-strengths">
                        <h3>üåü Shiseido</h3>
                        <ul>
                            <li>Pionnier historique (ann√©es 80)</li>
                            <li>Expertise gal√©nique de pointe</li>
                            <li>Leadership Asie-Pacifique</li>
                            <li>Recherche multi-cible avanc√©e</li>
                        </ul>
                    </div>
                    <div class="swot-card swot-opportunities">
                        <h3>üöÄ √âmergents</h3>
                        <ul>
                            <li>Agilit√© / innovation rapide</li>
                            <li>Communaut√© engag√©e</li>
                            <li>Prix accessibles</li>
                            <li>Formules transparentes</li>
                        </ul>
                    </div>
                </div>
            </div>
        </div>

        <!-- SECTION 5: STRAT√âGIE ACM -->
        <div id="strategy" class="section">
            <div class="card">
                <h2>üéØ Recommandations Strat√©giques pour ACM</h2>

                <div class="recommendation-box priority-high">
                    <h3>üî¥ PRIORIT√â 1: D√©velopper un actif propri√©taire innovant</h3>
                    <p><strong>Rationale:</strong> Thiamidol et Melasyl prouvent qu'un ingr√©dient signature = diff√©renciation majeure</p>
                    <p><strong>Approche:</strong></p>
                    <ul style="margin: 10px 0 10px 20px;">
                        <li>Criblage mol√©culaire cibl√© sur nouvelles cibles (VEGF, inflammation, transfert m√©lanosomes)</li>
                        <li>Approche multi-cible: inhibition tyrosinase + anti-inflammatoire + anti-vasculaire</li>
                        <li>Focus s√©curit√© long terme (utilisation > 6 mois sans risques)</li>
                        <li>Tests cliniques robustes sur phototypes IV-VI (march√© prioritaire)</li>
                    </ul>
                    <p><strong>Timeline:</strong> 3-5 ans R&D ‚Üí Brevet ‚Üí Lancement</p>
                    <p><strong>Budget estim√©:</strong> ‚Ç¨5-10M R&D</p>
                </div>

                <div class="recommendation-box priority-high">
                    <h3>üî¥ PRIORIT√â 2: Formulation gal√©nique avanc√©e</h3>
                    <p><strong>Opportunit√©:</strong> Shiseido montre que la gal√©nique = avantage comp√©titif majeur</p>
                    <p><strong>Actions:</strong></p>
                    <ul style="margin: 10px 0 10px 20px;">
                        <li>D√©velopper syst√®me vectorisation (liposomes, nanovecteurs) pour p√©n√©tration optimale</li>
                        <li>Technologie "ionic liquid" ou √©quivalent pour maintenir actifs stables + biodisponibles</li>
                        <li>Textures sensorielles premium (absorption rapide, fini mat/satin√©)</li>
                        <li>Protection lumi√®re visible (√©crans teint√©s, filtres anti-lumi√®re bleue)</li>
                    </ul>
                    <p><strong>Avantage:</strong> Maximiser efficacit√© actifs existants sans augmenter concentrations</p>
                </div>

                <div class="recommendation-box priority-high">
                    <h3>üü† PRIORIT√â 3: Ciblage g√©ographique strat√©gique</h3>
                    <p><strong>March√© primaire:</strong> Asie-Pacifique (50% march√© mondial, forte demande, maturit√© √©lev√©e)</p>
                    <p><strong>Strat√©gie:</strong></p>
                    <ul style="margin: 10px 0 10px 20px;">
                        <li><strong>Chine:</strong> Partenariats distributeurs locaux, adaptation formules climat humide</li>
                        <li><strong>Cor√©e:</strong> Positionnement premium, collaboration K-Beauty influenceurs</li>
                        <li><strong>Japon:</strong> Validation dermatologique, quasi-drug approval si possible</li>
                        <li><strong>Inde:</strong> Gamme accessible (price point ‚Ç¨15-30), focus HPI post-acn√©</li>
                    </ul>
                    <p><strong>March√© secondaire:</strong> Moyen-Orient + Afrique du Nord (forte pr√©valence m√©lasma, pouvoir d'achat)</p>
                </div>

                <div class="recommendation-box priority-medium">
                    <h3>üü° PRIORIT√â 4: Gamme diff√©renci√©e par besoin</h3>
                    <p><strong>Produit 1:</strong> S√©rum intensif m√©lasma rebelle (actif propri√©taire + tranexamique topique + niacinamide)</p>
                    <p><strong>Produit 2:</strong> Cr√®me quotidienne HPI post-acn√© peaux noires (az√©la√Øque + actif propri√©taire + apaisant)</p>
                    <p><strong>Produit 3:</strong> Booster √©clat lentigos solaires (vitamine C stabilis√©e + actif propri√©taire + AHA l√©gers)</p>
                    <p><strong>Produit 4:</strong> SPF 50+ teint√© anti-r√©cidive (UVA/UVB/lumi√®re visible + entretien d√©pigmentation)</p>
                    <p><strong>Positionnement:</strong> Solutions sp√©cialis√©es (vs produits "one-size-fits-all")</p>
                </div>

                <div class="recommendation-box priority-medium">
                    <h3>üü° PRIORIT√â 5: Validation clinique & communication scientifique</h3>
                    <p><strong>Cr√©dibilit√© = cl√© du succ√®s en pharmacie</strong></p>
                    <ul style="margin: 10px 0 10px 20px;">
                        <li>√âtudes cliniques comparatives vs gold standards (HQ, triple th√©rapie, thiamidol)</li>
                        <li>Publications revues dermatologiques peer-reviewed</li>
                        <li>Pr√©sentations congr√®s (AAD, EADV, World Congress Dermatology)</li>
                        <li>Programme formation dermatologues/pharmaciens</li>
                        <li>Donn√©es chiffr√©es transparentes (% am√©lioration √† 4-12 semaines)</li>
                    </ul>
                    <p><strong>Message:</strong> "Efficacit√© clinique prouv√©e + S√©curit√© long terme"</p>
                </div>

                <div class="recommendation-box priority-low">
                    <h3>üü¢ PRIORIT√â 6: Marketing digital & √©ducation consommateur</h3>
                    <p><strong>Opportunit√©:</strong> √âmergents (Topicals) montrent le pouvoir des communaut√©s en ligne</p>
                    <ul style="margin: 10px 0 10px 20px;">
                        <li>Contenu √©ducatif: Blog/YouTube expliquant m√©canismes, actifs, routines</li>
                        <li>Partenariats dermatologues influenceurs (Instagram, TikTok)</li>
                        <li>Application mobile: diagnostic taches + routine personnalis√©e + suivi progr√®s</li>
                        <li>Avant/apr√®s authentiques (diversit√© phototypes)</li>
                        <li>Transparence composition (% actifs, CoA disponibles)</li>
                    </ul>
                </div>
            </div>

            <div class="dashboard-grid">
                <div class="card">
                    <h2>üí∞ Analyse d'Opportunit√© de March√©</h2>
                    <div class="key-metric">
                        <div class="key-metric-value">‚Ç¨850M</div>
                        <div class="key-metric-label">TAM Europe Hyperpigmentation</div>
                    </div>
                    <div class="key-metric" style="background: linear-gradient(135deg, #f093fb 0%, #f5576c 100%);">
                        <div class="key-metric-value">‚Ç¨4,4 Mds</div>
                        <div class="key-metric-label">TAM Asie-Pacifique</div>
                    </div>
                    <div class="key-metric" style="background: linear-gradient(135deg, #fa709a 0%, #fee140 100%);">
                        <div class="key-metric-value">1%</div>
                        <div class="key-metric-label">Part de march√© cible r√©aliste ‚Üí ‚Ç¨85M CA</div>
                    </div>
                </div>

                <div class="card">
                    <h2>‚è±Ô∏è Roadmap Strat√©gique</h2>
                    <div class="timeline">
                        <div class="timeline-item" style="border-color: #f5576c;">
                            <h3>Phase 1: R&D (Ann√©es 1-3)</h3>
                            <p>D√©veloppement actif propri√©taire + formulation gal√©nique + √©tudes pr√©cliniques</p>
                        </div>
                        <div class="timeline-item" style="border-color: #ff9800;">
                            <h3>Phase 2: Validation (Ann√©es 3-5)</h3>
                            <p>Essais cliniques multi-centres + publications + dossier r√©glementaire</p>
                        </div>
                        <div class="timeline-item" style="border-color: #4caf50;">
                            <h3>Phase 3: Lancement (Ann√©e 5-6)</h3>
                            <p>Lancement Europe + Formation dermatos/pharmaciens + Digital marketing</p>
                        </div>
                        <div class="timeline-item" style="border-color: #2196f3;">
                            <h3>Phase 4: Expansion (Ann√©e 6-10)</h3>
                            <p>D√©ploiement Asie-Pacifique + Extension gamme + Acquisitions croissance externe</p>
                        </div>
                    </div>
                </div>
            </div>

            <div class="card">
                <h2>‚öñÔ∏è Analyse SWOT pour ACM</h2>
                <div class="swot-grid">
                    <div class="swot-card swot-strengths">
                        <h3>üí™ Forces</h3>
                        <ul>
                            <li>Expertise dermatologique √©tablie</li>
                            <li>R√©seau pharmacies europ√©ennes</li>
                            <li>Laboratoire R&D op√©rationnel</li>
                            <li>Image scientifique cr√©dible</li>
                            <li>Flexibilit√© PME (agilit√© vs g√©ants)</li>
                        </ul>
                    </div>
                    <div class="swot-card swot-weaknesses">
                        <h3>‚ö†Ô∏è Faiblesses</h3>
                        <ul>
                            <li>Notori√©t√© limit√©e vs L'Or√©al/Shiseido</li>
                            <li>Budget R&D < concurrents</li>
                            <li>Absence actif signature reconnu</li>
                            <li>Distribution Asie-Pacifique absente</li>
                            <li>Pr√©sence digital/social m√©dia faible</li>
                        </ul>
                    </div>
                    <div class="swot-card swot-opportunities">
                        <h3>üåü Opportunit√©s</h3>
                        <ul>
                            <li>March√© +78% d'ici 2030</li>
                            <li>Interdiction HQ = besoin alternatives</li>
                            <li>Peaux fonc√©es sous-servies Europe</li>
                            <li>M√©lasma rebelle = niche premium</li>
                            <li>Transparence/clean beauty tendance</li>
                            <li>T√©l√©m√©decine dermatologique croissante</li>
                        </ul>
                    </div>
                    <div class="swot-card swot-threats">
                        <h3>‚ö° Menaces</h3>
                        <ul>
                            <li>Concurrence intense (g√©ants + √©mergents)</li>
                            <li>Thiamidol/Melasyl d√©j√† √©tablis</li>
                            <li>R√©glementation stricte Europe</li>
                            <li>Produits ill√©gaux (mercure) brouillent march√©</li>
                            <li>Attentes consommateurs √©lev√©es (r√©sultats rapides)</li>
                        </ul>
                    </div>
                </div>
            </div>

            <div class="card">
                <h2>üéØ Positionnement Strat√©gique Recommand√©</h2>
                <div style="background: linear-gradient(135deg, #667eea 0%, #764ba2 100%); color: white; padding: 30px; border-radius: 15px; text-align: center;">
                    <h3 style="font-size: 1.8em; margin-bottom: 20px; color: white;">¬´ Le sp√©cialiste europ√©en des hyperpigmentations rebelles ¬ª</h3>
                    <p style="font-size: 1.2em; line-height: 1.6;">
                        <strong>Promesse:</strong> Solutions scientifiquement valid√©es pour les cas r√©sistants (m√©lasma r√©cidivant, HPI peaux fonc√©es)<br>
                        <strong>Diff√©renciation:</strong> Actif propri√©taire multi-cible + Gal√©nique avanc√©e + Expertise dermatologique<br>
                        <strong>Circuit:</strong> Prescription dermato + Conseil pharmacien (pas grande distribution)<br>
                        <strong>Prix:</strong> Premium justifi√© (‚Ç¨40-60 produit) par efficacit√© clinique<br>
                        <strong>Extension:</strong> Leader Europe ‚Üí Expansion Asie via partenariats
                    </p>
                </div>
            </div>
        </div>

        <!-- SECTION 6: ANALYSE R√âGIONALE -->
        <div id="regions" class="section">
            <div class="card">
                <h2>üåè Asie-Pacifique: Le March√© Prioritaire</h2>
                <div class="stat-box">
                    <div class="stat-label">Part du march√© mondial</div>
                    <div class="stat-number">>50%</div>
                </div>
                <h3 style="margin: 20px 0 10px 0; color: #2a5298;">Caract√©ristiques</h3>
                <ul class="insights-list">
                    <li><strong>Maturit√©:</strong> ‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê Innovation constante, consommatrices √©duqu√©es</li>
                    <li><strong>Japon:</strong> Pionnier r√©gulation (quasi-drugs ann√©es 80), tranexamique approuv√© cosm√©tique</li>
                    <li><strong>Cor√©e:</strong> K-Beauty mondiale, routines multilayers, s√©rums/essences/masques</li>
                    <li><strong>Chine:</strong> Classe moyenne massive, croissance forte, marques locales + importations</li>
                    <li><strong>Prix accept√©:</strong> ‚Ç¨30-100+ pour produits premium haute technologie</li>
                </ul>
                <h3 style="margin: 20px 0 10px 0; color: #2a5298;">Leaders R√©gionaux</h3>
                <p>Shiseido (4MSK, White Lucent), AmorePacific (Melasolv, Sulwhasoo), SK-II, Sulwhasoo</p>
                <h3 style="margin: 20px 0 10px 0; color: #2a5298;">Recommandation ACM</h3>
                <div class="recommendation-box">
                    <p>‚úÖ Partenariat distributeur Chine (Tmall, JD.com)</p>
                    <p>‚úÖ Collaboration KOL beaut√© Cor√©e (Instagram/YouTube)</p>
                    <p>‚úÖ Positionnement "European expertise" (prestige occidental valoris√©)</p>
                    <p>‚úÖ Adaptation textures (climat humide, absorption rapide)</p>
                </div>
            </div>

            <div class="card">
                <h2>üá™üá∫ Europe: March√© R√©glement√© & Mature</h2>
                <h3 style="margin: 20px 0 10px 0; color: #2a5298;">Caract√©ristiques</h3>
                <ul class="insights-list">
                    <li><strong>Maturit√©:</strong> ‚≠ê‚≠ê‚≠ê‚≠ê Haute technologie, march√© m√©dicalis√©</li>
                    <li><strong>Focus:</strong> Anti-√¢ge + taches soleil (vs blanchiment global)</li>
                    <li><strong>R√©glementation:</strong> La plus stricte mondiale (HQ interdite 2001, mercure banni)</li>
                    <li><strong>Circuit:</strong> Pharmacie dominante (La Roche-Posay, Vichy, Bioderma, Caudalie)</li>
                    <li><strong>Consommateurs:</strong> Exigent preuves cliniques, liste INCI transparente</li>
                </ul>
                <h3 style="margin: 20px 0 10px 0; color: #2a5298;">Opportunit√© Sp√©cifique</h3>
                <div class="recommendation-box">
                    <p><strong>Peaux fonc√©es sous-servies:</strong> Communaut√©s africaines/moyen-orientales en Europe</p>
                    <p><strong>Besoin:</strong> Solutions HPI post-acn√©, m√©lasma peaux mates, alternatives HQ s√ªres</p>
                    <p><strong>Positionnement ACM:</strong> "Sp√©cialiste phototypes IV-VI en Europe"</p>
                </div>
            </div>

            <div class="dashboard-grid">
                <div class="card">
                    <h2>üá∫üá∏ Am√©rique du Nord</h2>
                    <h3 style="color: #2a5298;">Caract√©ristiques</h3>
                    <ul class="insights-list">
                        <li><strong>Diversit√© ethnique:</strong> Afro-am√©ricains, latinos, asiatiques + caucasiens</li>
                        <li><strong>R√©glementation:</strong> HQ <2% √©tait OTC, maintenant prescription seule (FDA 2020)</li>
                        <li><strong>Cosmeceutiques:</strong> Segment fort (SkinCeuticals, Obagi, PCA Skin, Murad)</li>
                        <li><strong>Transparence:</strong> The Ordinary = succ√®s (formules brutes, prix bas, INCI claire)</li>
                    </ul>
                    <h3 style="color: #2a5298;">Recommandation ACM</h3>
                    <p>‚ö†Ô∏è March√© secondaire (concurrence intense, barri√®res entr√©e √©lev√©es)</p>
                    <p>‚úÖ Si expansion: Positionnement "European science" premium via Dermstore/Sephora</p>
                </div>

                <div class="card">
                    <h2>üåç Afrique & Moyen-Orient</h2>
                    <h3 style="color: #2a5298;">Caract√©ristiques</h3>
                    <ul class="insights-list">
                        <li><strong>Demande:</strong> Tr√®s forte (30-60% femmes utilisent √©claircissants)</li>
                        <li><strong>Probl√®me:</strong> March√© pollu√© produits dangereux (mercure, st√©ro√Ødes)</li>
                        <li><strong>Interdictions:</strong> Ghana, Rwanda, Afrique du Sud bannissent HQ/mercure</li>
                        <li><strong>Besoin:</strong> Alternatives s√ªres et r√©glement√©es, √©ducation sant√©</li>
                    </ul>
                    <h3 style="color: #2a5298;">Recommandation ACM</h3>
                    <p>‚úÖ Opportunit√© sociale + business: Offrir produits s√ªrs accessibles (‚Ç¨20-40)</p>
                    <p>‚úÖ Partenariats pharmacies Afrique du Nord / Afrique du Sud</p>
                    <p>‚úÖ Campagnes √©ducation risques mercure/cortico√Ødes</p>
                </div>
            </div>

            <div class="card">
                <h2>üó∫Ô∏è Matrice de Priorisation G√©ographique ACM</h2>
                <table style="width: 100%; border-collapse: collapse; margin-top: 20px;">
                    <thead style="background: linear-gradient(135deg, #667eea 0%, #764ba2 100%); color: white;">
                        <tr>
                            <th style="padding: 15px; text-align: left;">R√©gion</th>
                            <th style="padding: 15px;">Taille March√©</th>
                            <th style="padding: 15px;">Accessibilit√© ACM</th>
                            <th style="padding: 15px;">Concurrence</th>
                            <th style="padding: 15px;">Priorit√©</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr style="background: #f1f8f4;">
                            <td style="padding: 12px;"><strong>Europe Ouest</strong></td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px;"><span class="tag" style="background: #4caf50;">üü¢ P1</span></td>
                        </tr>
                        <tr>
                            <td style="padding: 12px;"><strong>Asie-Pacifique</strong></td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê</td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px;"><span class="tag" style="background: #4caf50;">üü¢ P1</span></td>
                        </tr>
                        <tr style="background: #fffaf0;">
                            <td style="padding: 12px;"><strong>Moyen-Orient / Afr. Nord</strong></td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px;"><span class="tag" style="background: #ff9800;">üü† P2</span></td>
                        </tr>
                        <tr>
                            <td style="padding: 12px;"><strong>Afrique Subsaharienne</strong></td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê</td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê</td>
                            <td style="padding: 12px;"><span class="tag" style="background: #ff9800;">üü† P2</span></td>
                        </tr>
                        <tr style="background: #fff5f5;">
                            <td style="padding: 12px;"><strong>Am√©rique du Nord</strong></td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px; text-align: center;">‚≠ê</td>
                            <td style="padding: 12px; text-align: center;">‚≠ê‚≠ê‚≠ê‚≠ê‚≠ê</td>
                            <td style="padding: 12px;"><span class="tag" style="background: #f44336;">üî¥ P3</span></td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>
    </div>

    <script>
        // NAVIGATION
        function showSection(sectionId) {
            document.querySelectorAll('.section').forEach(s => s.classList.remove('active'));
            document.querySelectorAll('.nav-btn').forEach(b => b.classList.remove('active'));
            document.getElementById(sectionId).classList.add('active');
            event.target.classList.add('active');
        }

        // CHART 1: Types d'Hyperpigmentation
        const typesCtx = document.getElementById('typesChart').getContext('2d');
        new Chart(typesCtx, {
            type: 'doughnut',
            data: {
                labels: ['M√©lasma', 'Lentigos Solaires', 'HPI Post-Acn√©', 'HPI Post-Inflammatoire', 'Autres'],
                datasets: [{
                    data: [35, 25, 20, 15, 5],
                    backgroundColor: [
                        '#f5576c',
                        '#ffa500',
                        '#667eea',
                        '#764ba2',
                        '#95a5a6'
                    ]
                }]
            },
            options: {
                responsive: true,
                maintainAspectRatio: false,
                plugins: {
                    legend: {
                        position: 'bottom',
                        labels: {
                            font: { size: 12 }
                        }
                    },
                    title: {
                        display: true,
                        text: 'R√©partition des cas d\'hyperpigmentation'
                    }
                }
            }
        });

        // CHART 2: R√©partition G√©ographique
        const geoCtx = document.getElementById('geoChart').getContext('2d');
        new Chart(geoCtx, {
            type: 'bar',
            data: {
                labels: ['Asie-Pacifique', 'Afrique', 'Am√©rique Nord', 'Europe', 'Moyen-Orient', 'Am. Latine'],
                datasets: [{
                    label: 'Part de march√© (%)',
                    data: [52, 18, 12, 9, 5, 4],
                    backgroundColor: [
                        '#f5576c',
                        '#ffa500',
                        '#667eea',
                        '#764ba2',
                        '#4caf50',
                        '#2196f3'
                    ]
                }]
            },
            options: {
                responsive: true,
                maintainAspectRatio: false,
                plugins: {
                    legend: { display: false },
                    title: {
                        display: true,
                        text: 'March√© mondial par r√©gion (2022)'
                    }
                },
                scales: {
                    y: {
                        beginAtZero: true,
                        max: 60
                    }
                }
            }
        });

        // CHART 3: Segmentation Client
        const segmentCtx = document.getElementById('segmentChart').getContext('2d');
        new Chart(segmentCtx, {
            type: 'pie',
            data: {
                labels: ['Femmes teint mat/fonc√©', 'Femmes teint clair', 'Hommes', 'Autres'],
                datasets: [{
                    data: [65, 20, 10, 5],
                    backgroundColor: ['#f093fb', '#f5576c', '#667eea', '#95a5a6']
                }]
            },
            options: {
                responsive: true,
                maintainAspectRatio: false,
                plugins: {
                    legend: {
                        position: 'bottom',
                        labels: { font: { size: 12 } }
                    }
                }
            }
        });

        // CHART 4: Nouvelles Cibles Th√©rapeutiques
        const targetsCtx = document.getElementById('targetsChart').getContext('2d');
        new Chart(targetsCtx, {
            type: 'radar',
            data: {
                labels: ['Tyrosinase', 'Inflammation', 'VEGF/Vascularisation', 'Transfert M√©lanosomes', 'SCF/c-kit', 'Exfoliation'],
                datasets: [{
                    label: 'Approche Classique (HQ)',
                    data: [95, 20, 10, 30, 15, 40],
                    borderColor: '#f5576c',
                    backgroundColor: 'rgba(245, 87, 108, 0.2)'
                }, {
                    label: 'Approche Multi-Cible Moderne',
                    data: [85, 75, 70, 80, 65, 75],
                    borderColor: '#667eea',
                    backgroundColor: 'rgba(102, 126, 234, 0.2)'
                }]
            },
            options: {
                responsive: true,
                maintainAspectRatio: false,
                scales: {
                    r: {
                        beginAtZero: true,
                        max: 100
                    }
                }
            }
        });

        // CHART 5: Parts de March√©
        const marketShareCtx = document.getElementById('marketShareChart').getContext('2d');
        new Chart(marketShareCtx, {
            type: 'doughnut',
            data: {
                labels: ['L\'Or√©al', 'Shiseido', 'Beiersdorf', 'AmorePacific', 'Galderma', 'Autres'],
                datasets: [{
                    data: [22, 15, 12, 10, 6, 35],
                    backgroundColor: ['#f5576c', '#ffa500', '#667eea', '#764ba2', '#4caf50', '#95a5a6']
                }]
            },
            options: {
                responsive: true,
                maintainAspectRatio: false,
                plugins: {
                    legend: { position: 'bottom' },
                    title: {
                        display: true,
                        text: 'Parts de march√© estim√©es (2024)'
                    }
                }
            }
        });

        // CHART 6: Budget R&D
        const rdBudgetCtx = document.getElementById('rdBudgetChart').getContext('2d');
        new Chart(rdBudgetCtx, {
            type: 'bar',
            data: {
                labels: ['L\'Or√©al', 'Shiseido', 'Beiersdorf', 'AmorePacific', 'Galderma'],
                datasets: [{
                    label: 'Budget R&D Annuel (M‚Ç¨)',
                    data: [1000, 300, 200, 180, 120],
                    backgroundColor: ['#f5576c', '#ffa500', '#667eea', '#764ba2', '#4caf50']
                }]
            },
            options: {
                responsive: true,
                maintainAspectRatio: false,
                plugins: {
                    legend: { display: false }
                },
                scales: {
                    y: {
                        beginAtZero: true
                    }
                }
            }
        });

        // Animation au scroll
        const cards = document.querySelectorAll('.card');
        const observerOptions = {
            threshold: 0.1,
            rootMargin: '0px 0px -50px 0px'
        };

        const observer = new IntersectionObserver((entries) => {
            entries.forEach(entry => {
                if (entry.isIntersecting) {
                    entry.target.style.opacity = '1';
                    entry.target.style.transform = 'translateY(0)';
                }
            });
        }, observerOptions);

        cards.forEach(card => {
            card.style.opacity = '0';
            card.style.transform = 'translateY(20px)';
            card.style.transition = 'all 0.6s ease';
            observer.observe(card);
        });
    </script>
</body>
</html>